Purpose and outline
Nerve Conduction Studies are a diagnostic test to assess the function of peripheral nerves.
Information about this service
Local incentive scheme.
Example components for this service
Number of procedures conducted – Test 1.
Number of procedures conducted – Test 2.
Follow up appointments with patients.
Declaration.
Purpose and outline
The National Enhanced Service (NES) Immediate Care/First Response Care refers to a service that provides rapid, skilled medical assistance in emergency situations. It augments the ambulance service.
Information about this service
Local incentive scheme.
Example components for this service
Specialised ICFR training for GPs – in hours.
Number of incidents at practice.
Declaration.
Purpose and outline
NPT Antipsychotics refers to medications sometimes prescribed to manage neuropsychiatric symptoms.
Information about this service
Local incentive scheme.
Example components for this service
Number of consultations for newly prescribed patients.
Number of follow on appointments.
Declaration.
Purpose and outline
Fitting service for long-acting reversible contraception (LARC).
Information about this service
Local incentive scheme.
Example components for this service
Number of LARC fittings.
Follow up appointments with patients.
Declaration.
Information about this service
Local incentive scheme.
Example components for this service
Number of level 1 patients seen.
Number of level 2 patients seen.
Number of home visits.
Declaration.
Purpose and outline
GP registrations relating to patients from Nepalese orgin.
Information about this service
Local incentive scheme.
Example components for this service
Number of Nepalese patients at a practice.
Number of hours of translator services used.
Declaration.
Purpose and outline
The National Diabetes Audit (NDA) supports NHS England (NHSE) in ensuring practices meet contractual requirement set out in the GMS Contract Regulations. It ensures standardised care and improved patient outcomes and provides management information to support practices and commissioners understand their performance and identify areas for improvement.
The NDA is part of the National Clinical Audit Programme commissioned by NHSE. It was established in 2004 and measures the quality of diabetes care against the National Institute of Clinical Excellence (NICE) recommended standards and current policies, including the NHS Five Year Forward View. It is used in a number of cardiovascular risk tools such as the Diabetes versus Expenditure Tool and Rightcare Atlas of Variation. It provides key indicators for the measurement of patient care, service improvements and quality standards. The NDA is the only source of diabetes information that offers patient-level analysis and the ability to track changes over time.
Information about this service:
- Quality service start date: 1st April 2017
- Quality service end date: 31st March 2029
- Collection frequency: Quarterly
- Included in data collection: All system suppliers (Cegedim, EMIS and TPP)
- Co-commissioning: No
- System type: GPES service
Purpose and outline
The purpose of the National Obesity Audit (NOA) service is to support NHS England to see the landscape of care and resources available for people living with overweight and obesity. It ensures standardised care and improved patient outcomes and provides relevant management information to support providers and commissioners understand their performance and to ensure they meet their contractual requirements.
It provides the ability to monitor aspects of the National Obesity Strategy including the impact of additional weight management services as well as commitments in the NHS Long Term Plan.
How this service is commissioned and provided
This service is offered out by NHS England for GP practices to accept.
Information about this service:
- Quality service start date: 1 October 2023
- Quality service end date: 31 March 2029
- Payment period: Participation only service in CQRS.